About Fredric Price
Fredric Price is chairman and chief executive officer of NBO Pharma. The company is testing nasal octreotide for idiopathic intracranial hypertension.
He also served as chairman of Omrix Biopharmaceuticals.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Fredric Price in the role, so the role may have started earlier or lasted longer.
NBO Pharma Inc. Current
Chairman & Chief Executive Officer
2026 – Present · Bedford, NY
NBO is testing nasal octreotide as a treatment for idiopathic intracranial hypertension.
OI
Omrix Biopharmaceuticals, Inc.
Chairman of the Board
Key Colleagues at Startups
The people Fredric Price works with at each company, as listed on that company's latest Form D.
NBO Pharma Inc. · Form D, Nov 9, 2026